Live Breaking News & Updates on Drug Major

Stay updated with breaking news from Drug major. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Merck Lifts FY24 Outlook After Higher Q1 Earnings, Above Market; Stock Up In Pre-market

Drug major Merck & Co., Inc. (MRK), while reporting higher first-quarter earnings, above market estimates, on Thursday raised its fiscal 2024 adjusted earnings and sales view. ....

Thomson Reuters , Merck Co Inc , Drug Major , Erck Earnings ,

Sanofi Q1 Profit Weak, But Sales Rise; Backs FY24 View; Stock Up

French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. ....

France General , Paul Hudson , Chief Executive Officer , Consumer Healthcare , Mental Wellness , Digestive Wellness , Drug Major , Anofi Earnings , Usiness Net Income , French Drug ,

Pfizer Sees FY24 Adj. EPS, Revenues Below Market; Stock Down In Pre Market

Drug major Pfizer Inc. (PFE) on Wednesday said it expects higher adjusted earnings and revenues for fiscal 2024, but both below market estimates. In pre-market activity on the NYSE, the shares were losing around 7. ....

Albert Bourla , Thomson Reuters , Pfizer Inc , Pfizer Chairman , Chief Executive Officer , Drug Major , Fizer Outlook , Below Market ,

GSK Lifts FY23 Outlook As Q3 Profit From Cont. Opns Surges

British drug major GSK Plc on Wednesday lifted its fiscal 2023 forecast for earnings and sales after reporting higher third-quarter profit on continuing operations basis. ....

City Of , United Kingdom , Emma Walmsley , Plc On , General Medicines , Specialty Medicines , Drug Major , Consumer Healthcare , Rsv Vaccine , Sk Earnings , Emma Walmsley , Gsk Plc ,

Sanofi Q3 Profit Rises, Backs FY23 View, To Split Consumer Healthcare Unit; Stock Dips

French drug major Sanofi reported Friday higher profit in its third quarter, while sales declined. Further, the company reiterated fiscal 2023 business earnings view. ....

France General , Paul Hudson , Consumer Healthcare Business , Chief Executive Officer , Drug Major , Anofi Earnings , Rench Drug Major ,